Embedding biobanks as tools for personalised medicine

Norsk Epidemiologi

Volumn 21, Issue 2, 2012, Pages 169-175

  Kaye, Jane ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; HEALTH CARE FACILITY; MEDICOLEGAL ASPECT; NONBIOLOGICAL MODEL; PARTICIPATORY MANAGEMENT; PATIENT INFORMATION; PATIENT PARTICIPATION; PATIENT RIGHT; PERSONALIZED MEDICINE; PRIVACY; PUBLIC-PRIVATE PARTNERSHIP; RESEARCH ETHICS; TRANSLATIONAL RESEARCH;

EID: 84862996020     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v21i2.1490     Document Type: Article

References (41)

1. Green ED, Guyer MS, National Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011; 470: 204-13.
2. Paik S, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 2817-26.
3. Tozzi V. Pharmacogenetics of antiretrovirals. Antiviral Res 2010; 85: 190-200.
4. Angiolillo DJ, et al. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler Thromb Vasc Biol 2006; 26: 1895-1900.
5. Rieder MJ, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005; 352: 2285-93.
6. Goetz MP, et al. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat 2007; 101: 113-21.
7. Feero WG, Guttmacher AE, Collins FS. Genomic medicine-An updated primer. N Engl J Med 2010; 362: 2001-11.
8. Califf RM, Peterson ED, Gibbons RJ, et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol 2002; 40: 1895-901.
9. Lee TH. Eulogy for a quality measure. N Engl J Med 2007; 357: 1175-7.
10. Balas EA. Information systems can prevent errors and improve quality. J Am Med Inform Assoc 2001; 8: 398-9.
11. Bioscience Innovation and Growth Team: The Review and Refresh of Bioscience 2015. A Report to Government. UK Department for Business, Enterprise and Regulatory Reform, January 2009.
12. Califf RM, Peterson ED, Gibbons RJ, et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol 2002; 40: 1895-901.
13. Feldman A. CTS: A new discipline to catalyze the transfer of information. Clin Transl Sci 2008: 1: 1-2.
14. Budin-Ljøsne I, Tassé AM, Knoppers BM, Harris JR. Bridging consent: from toll bridges to lift bridges? BMC Med Genomics 2011; 4: 69.
15. Talmon JL, Maurits GR, Legemate DA. PSI: The Dutch Academic Infrastructure for shared biobanks for translational research. Summit on Translat Bioinforma 2008: 110-4.
16. Schmittdiel JA, et al. System-based participatory research in health care: an approach for sustainable translational research and quality improvement. Ann Fam Med 2010; 8: 256-9.
17. Bonham AC, et al. Putting evidence to work: an expanded research agenda for academic medicine in the era of health care reform. Acad Med 2010; 85: 1551-3.
18. Harris PA, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (2): 377-81.
19. Clancy C, Collins FS. Patient-Centered Outcomes Research Institute: The intersection of science and health care. Sci Transl Med 2010; 2: 37cm18.
20. BBMRI Brochure, October 2010.
21. Caulfield T, Kaye J. Broad consent in biobanking: reflections on seemingly insurmountable dilemmas. Med Law Int 2009; 10: 85-100.
22. Kaye J. Data sharing and privacy in genomic research. Annu Rev Genomics Hum Genet 2012; 13 (in press).
23. Trinidad SB, Fullerton SM, Ludman EJ, Jarvik GP, Larson EB, Burke W. Research ethics. Research practice and participant preferences: the growing gulf. Science 2011; 331 (6015): 287-8.
24. Ledford H. Translational research: 4 ways to fix the clinical trial. Nature 2011; 477: 526-8.
25. Maxmen A. Translational research: The American way. Nature 2011; 478: S16-8.
26. Forrest LE, Delatycki MB, Skene L, Aitken M. Communicating genetic information in families-a review of guidelines and position papers. Eur J Hum Genet 2007; 15: 612-8.
27. Marshall E. Human genetics in the clinic, one click away. Science 2011; 331: 528-9.
28. Cho MK. Understanding incidental findings in the context of genetics and genomics. J Law Med Ethics 2008; 36: 280-5.
29. Hardcastle R. Law and the Human Body: property rights, ownership and control. Oxford: Hart, 2007.
30. Harris PA, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (2): 377-81.
31. Mason JK, Laurie GT. Consent or property? Dealing with the body and its parts in the shadow of Bristol and Alder Hey. Mod Law Rev 2001; 64: 710-29.
32. Haddow G, Laurie G, Cunningham-Burley S, Hunter KG. Tackling community concerns about commercialisation and genetic research: a modest interdisciplinary proposal. Soc Sci Med 2007; 64: 272-82.
33. Hopkins MM, et al. The Patenting of Human DNA: Global Trends in Public and Private Sector Activity (The PATGEN Project). SPRU, Science and Technology Policy Research, University of Sussex, 2006.
34. Clayton E. Informed consent and genetic research. In: Rothstein M (ed). Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. New Haven, CT: Yale University Press, 1997: 126-36.
35. Mascalzoni D, Hicks A, Pramstaller P, Wjst M. Informed consent in the genomics era. PLoS Med 2008; 5: e192.
36. Green ED, Guyer MS, National Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011; 470: 204-13.
37. Zarocostas J. Huge inequalities in access to drugs partly because of intellectual property rights, says UN Expert. BMJ 2009; 338: b2348.
38. Piper T, Gold R. Practice, Policies and Possibilities in Licensing in Human Genetics. The Innovation Partnership for Health Canada, 2008.
39. http://www.curarata.nl/.
40. Kaye J. From single biobanks to international networks: developing e-governance. Hum Genet 2011; 130: 377-82.
41. Malin B, Karp D, Scheuermann RH. Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research. J Investig Med 2010; 58: 11-8.